Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Toronto

$27,000.00

Functional Characterization of the T-cell acute lymphocytic leukemia 1 (TAL1) Risk Gene for Major Depressive Disorder

FY 2025-26

Summary
Emerging evidence suggests that major depressive disorder (MDD) may have neurodevelopmental origins, with early-life disruptions in gene regulation and neuronal signaling pathways contributing to increased disease vulnerability. One such gene of interest is TAL1 (T-cell acute lymphocytic leukemia 1), a transcription factor identified in genome-wide association studies of MDD. Numerous studies of the Tal1 gene in mice have demonstrated its role in neurodevelopment, including key features in cell differentiation and inhibitory neurotransmission. However, these effects have not been investigated in human cells, leading to a knowledge gap in the molecular understanding of TAL1’s transcriptional role in the developing brain and MDD risk. This study will investigate the effects of TAL1-mediated gene expression changes in human neural precursor cells using CRISPR to selectively alter TAL1 expression levels. I will investigate the effects of CRISPR-mediated overexpression and inhibition on downstream MDD risk gene expression, as well as the consequences for molecular pathways and potential therapeutic targets. This work will expand the field’s current understanding of the molecular underpinnings of neurodevelopmental and psychiatric disease, translating into clinically significant outcomes for future therapeutic work.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
573037
Name
Tullu Trusha K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Functional Characterization of the T-cell acute lymphocytic leukemia 1 (TAL1) Risk Gene for Major Depressive Disorder
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Crispr; Gene Expression; Major Depressive Disorder; Neural Precursor Cells; Neurodevelopment; Risk Gene; Tal1; Transcription Factor
Abstract
Emerging evidence suggests that major depressive disorder (MDD) may have neurodevelopmental origins, with early-life disruptions in gene regulation and neuronal signaling pathways contributing to increased disease vulnerability. One such gene of interest is TAL1 (T-cell acute lymphocytic leukemia 1), a transcription factor identified in genome-wide association studies of MDD. Numerous studies of the Tal1 gene in mice have demonstrated its role in neurodevelopment, including key features in cell differentiation and inhibitory neurotransmission. However, these effects have not been investigated in human cells, leading to a knowledge gap in the molecular understanding of TAL1’s transcriptional role in the developing brain and MDD risk. This study will investigate the effects of TAL1-mediated gene expression changes in human neural precursor cells using CRISPR to selectively alter TAL1 expression levels. I will investigate the effects of CRISPR-mediated overexpression and inhibition on downstream MDD risk gene expression, as well as the consequences for molecular pathways and potential therapeutic targets. This work will expand the field’s current understanding of the molecular underpinnings of neurodevelopmental and psychiatric disease, translating into clinically significant outcomes for future therapeutic work.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tullu, Trusha K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~